Nervgen Pharma (NGEN) Other Non Operating Income (2025 - 2026)
Nervgen Pharma (NGEN) posted quarterly Other Non Operating Income of -$22151.1 for Q1 2026, down 286.19% year-over-year from $11897.1 in Q1 2025, and down 286.19% quarter-over-quarter from $11897.1 in Q1 2025.
Nervgen Pharma (NGEN) Other Non Operating Income (2025 - 2026) Analysis & Trends
Nervgen Pharma (NGEN) has reported Other Non Operating Income for 2 consecutive years, with -$22151.1 the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Nervgen Pharma | 168.94 Mn | 168.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22,151.08 |
| Mar 31, 2025 | 11,897.06 |